CloverLeaf’s Investment Banking practice focuses on identifying and financing emerging growth companies as they expand and develop into tomorrow’s market leaders. We incorporate an efficient decision matrix into our funding review process CloverLeaf is a leader in providing emerging growth companies with ready access to the capital markets and a wide variety of advisory services. By focusing exclusively on emerging growth companies, CloverLeaf has developed an unparalleled understanding of these companies, their entrepreneurial managers and their highly specialized financing needs.

Our experience and capabilities in raising capital for private and public companies are the hallmarks of the firm. CloverLeaf and its principals have over $2 billion in capital and transaction experience in the small and micro cap market and completed over 185 merger, acquisition and advisory assignments. Since its inception, CloverLeaf has been a leading placement agent for PIPE transactions, and has facilitated IPO transactions for its portfolio companies.

CloverLeaf possesses domain expertise in e-learning, communications, media, health, manufacturing, real estate and technology. In considering a client companies, CloverLeaf examines product or service superiority, barriers to entry, market size, the business model, management team, and personal commitment.